1. Home
  2. Investing
  3. Stocks
  4. USA
  6. NeuroMetrix Inc (NURO)
  7. Quote


NeuroMetrix Stock Price

0.31 (4.35%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 504,564
Bid Price 7.41
Ask Price 19.20
News -
Day High 7.49


52 Week Range


Day Low 6.74
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NeuroMetrix Inc NURO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.31 4.35% 7.44 00:00:08
Open Price Low Price High Price Close Price Prev Close
6.88 6.74 7.49 7.44 7.13
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,446 504,564 $ 7.17 $ 3,619,807 - 1.90 - 38.75
Last Trade Time Type Quantity Stock Price Currency
16:53:56 formt 100 $ 7.4899 USD


Draw Mode:

NeuroMetrix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 49.66M 6.68M 6.64M $ 7.38M $ -1.41M -0.85 -22.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -70.00k 13.40%

more financials information »

NeuroMetrix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NURO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.848.086.407.081,401,7800.608.77%
1 Month7.658.906.407.43486,089-0.21-2.75%
3 Months11.4215.456.4010.531,276,118-3.98-34.85%
6 Months2.9038.752.850114.435,421,2124.54156.55%
1 Year2.0338.751.9012.983,161,6135.41266.5%
3 Years0.9938.750.251811.051,271,1246.45651.52%
5 Years9.2838.750.251810.18856,067-1.84-19.83%

NeuroMetrix Description

NeuroMetrix Inc is a commercial stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.